Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
32
Frequently Asked Questions
What is Market Cap of Angion Biomedica Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Angion Biomedica Corp market cap is $92.02M.
What is the 52-week high for Angion Biomedica Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Angion Biomedica Corp 52 week high is $24.39 as of September 14, 2025.
What is the 52-week low for Angion Biomedica Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Angion Biomedica Corp 52 week low is $2.96 as of September 14, 2025.
What is Angion Biomedica Corp stock price today?
Angion Biomedica Corp stock price today is $9.10.
What was Angion Biomedica Corp stock price yesterday?
Angion Biomedica Corp stock price yesterday was $8.99.
What is the PE ratio of Angion Biomedica Corp?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Angion Biomedica Corp’s P/E ratio is -1.46.
What is the Price-to-Book ratio of Angion Biomedica Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Angion Biomedica Corp P/B ratio is 7.5914.
What is Angion Biomedica Corp's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Angion Biomedica Corp's EBITDA is -2.28.
What is the 50-day moving average of Angion Biomedica Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Angion Biomedica Corp 50-day moving average is $6.61.
How many employess does Angion Biomedica Corp has?
